Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OsteoSys is a South Korea-based private medical device company focused on bone health, body composition, and musculoskeletal diagnostics. The company develops and manufactures bone mineral densitometers, DXA-based body composition analyzers, quantitative ultrasound systems, and related software for clinical, veterinary, and preclinical use. Its commercial portfolio addresses osteoporosis assessment, sarcopenia evaluation, skeletal muscular pain, and animal/laboratory applications rather than drug development. OsteoSys appears to be an operating, revenue-generating healthcare diagnostics business with products marketed internationally, including in Korea, China, Europe, and other export markets. For biotech and life sciences users, it is best classified as a diagnostics/medical technology company rather than a therapeutics biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Osteocys.